Buscar
Mostrando ítems 1-10 de 30
Alendronic acid produces greater effects than risedronic acid on bone density and turnover in postmenopausal women with osteoporosis - Results of FACTS-international
(Adis International LtdAucklandIrã, 2006)
Design of sodium risedronate-loaded poly(ɛ-caprolactone) nanoparticles: a promising approach for osteoporosis managementSodium risedronate-loaded poly(ε-caprolactone) nanoparticles: Development, physicochemical characterization, and in vitro drug release study
(Universidade Federal de Santa Maria, 2022)
Comparative therapeutic use of Risedronate and Calcarea phosphorica - Allopathy versus homeopathy - In bone repair in castrated rats
(2006-07-01)
Osteoporosis, a disease characterized by progressive bone loss, has been the target of several studies in the past few years. It results in a much higher risk for fractures and might cause slower bone lesion healing. The ...
Comparative therapeutic use of Risedronate and Calcarea phosphorica - Allopathy versus homeopathy - In bone repair in castrated rats
(2006-07-01)
Osteoporosis, a disease characterized by progressive bone loss, has been the target of several studies in the past few years. It results in a much higher risk for fractures and might cause slower bone lesion healing. The ...
Biomechanical and Microstructural Benefits of Physical Exercise Associated With Risedronate in Bones of Ovariectomized Rats
(Wiley-Blackwell, 2014-06-01)
Several treatments have been developed aiming the prevention of bone loss. There are discussions about the best prophylactic and therapeutic procedures for osteoporosis. This study evaluated the effects of physical exercise ...
Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: A network meta-analysis
(Oxford University Press, 2019)
Background: Osteoporosis and osteopenia are associated with increased fracture incidence in postmenopausal women. We aimed to determine the comparative effectiveness of various available pharmacological therapies. Methods: ...